The use of the serum lactate to serum Alb ratio (LAR) can improve the accuracy of prognosticating outcomes in patients with cerebral infarction by counterbalancing the effect of a singular factor on regulatory mechanisms through the contrasting effects induced by two separate mechanisms. This evidence concerns the gene ALB and cerebral infarction.